Growth Metrics

MDxHealth (MDXH) Net Income towards Common Stockholders (2021 - 2025)

Historic Net Income towards Common Stockholders for MDxHealth (MDXH) over the last 5 years, with Q3 2025 value amounting to -$8.0 million.

  • MDxHealth's Net Income towards Common Stockholders rose 2368.0% to -$8.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$14.3 million, marking a year-over-year increase of 6535.59%. This contributed to the annual value of -$38.1 million for FY2024, which is 1167.29% up from last year.
  • As of Q3 2025, MDxHealth's Net Income towards Common Stockholders stood at -$8.0 million, which was up 2368.0% from $9.4 million recorded in Q2 2025.
  • In the past 5 years, MDxHealth's Net Income towards Common Stockholders ranged from a high of $9.4 million in Q2 2025 and a low of -$18.1 billion during Q2 2022
  • Moreover, its 5-year median value for Net Income towards Common Stockholders was -$10.0 million (2023), whereas its average is -$1.1 billion.
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first tumbled by 9366.22% in 2022, then skyrocketed by 18158.48% in 2025.
  • Over the past 5 years, MDxHealth's Net Income towards Common Stockholders (Quarter) stood at -$8.1 million in 2021, then plummeted by 50.73% to -$12.2 million in 2022, then increased by 12.02% to -$10.7 million in 2023, then skyrocketed by 37.07% to -$6.7 million in 2024, then dropped by 18.93% to -$8.0 million in 2025.
  • Its last three reported values are -$8.0 million in Q3 2025, $9.4 million for Q2 2025, and -$8.9 million during Q1 2025.